Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 7
Submit an article Journal homepage
156
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation

Hari S. Ramana Harvard Medical School, Boston, MA, USA;b Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-6471-2144
ORCID Icon,
Vignesh Shanmugama Harvard Medical School, Boston, MA, USA;c Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
,
Jingwei Lia Harvard Medical School, Boston, MA, USA;c Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
,
David P. Steensmaa Harvard Medical School, Boston, MA, USA;d Dana-Farber Cancer Institute, Boston, MA, USA
,
Annette S. Kima Harvard Medical School, Boston, MA, USA;c Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
&
Marlise R. Luskina Harvard Medical School, Boston, MA, USA;d Dana-Farber Cancer Institute, Boston, MA, USACorrespondence[email protected]
Pages 1790-1792 | Received 12 Nov 2020, Accepted 19 Jan 2021, Published online: 13 Feb 2021

References

  • Fernandez HF, Sun Z, Yao X, et al. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med. 2009;361(13):1249–1259.
  • Pemmaraju N, Kantarjian H, Garcia-Manero G, et al. Improving outcomes for patients with acute myeloid leukemia in first relapse: a single center experience. Am J Hematol. 2015;90(1):27–30.
  • Luskin MR, Lee J-W, Fernandez HF, et al. Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups. Blood. 2016;127(12):1551–1558.
  • Parkin B, Ouillette P, Li Y, et al. Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia. Blood. 2013;121(2):369–377.
  • Cocciardi S, Dolnik A, Kapp-Schwoerer S, et al. Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation. Nat Commun. 2019;10(1):2031.
  • Rossi JG, Bernasconi AR, Alonso CN, et al. Lineage switch in childhood acute leukemia: an unusual event with poor outcome. Am J Hematol. 2012;87(9):890–897.
  • Kluk MJ, Lindsley RC, Aster JC, et al. Validation and Implementation of a custom next-generation sequencing clinical assay for hematologic malignancies. J Mol Diagnos. 2016;18(4):507–515.
  • Lin S, Luo RT, Ptasinska A, et al. Instructive role of MLL-fusion proteins revealed by a model of t(4;11) Pro-B acute lymphoblastic leukemia. Cancer Cell. 2016;30(5):737–749.
  • Jacoby E, Nguyen SM, Fountaine TJ, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7(1):12320.
  • Zoghbi A, Winkler B, Zur Stadt U, et al. Lineage switch under blinatumomab of a relapsed common ALL co-expressing myeloid markers without MLL rearrangement. Blood. 2016;128(22):5196–5196.
  • Höllein A, Meggendorfer M, Dicker F, et al. NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse. Blood Adv. 2018;2(22):3118–3125.
  • Jongen-Lavrencic M, Grob T, Hanekamp D, et al. Molecular minimal residual disease in acute myeloid leukemia. N Engl J Med. 2018;378(13):1189–1199.
  • Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477–2487.
  • Tokunaga K, Yamaguchi S, Iwanaga E, et al. High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia. Eur J Haematol. 2013;91(3):201–208.
  • Ilaria RL. Jr. Pathobiology of lymphoid and myeloid blast crisis and management issues. Hematology. 2005;2005(1):188–194.
  • Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126(1):9–16.
  • Lewis NE, Petrova-Drus K, Huet S, et al. Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. Blood Adv. 2020;4(10):2261–2271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.